Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Payables (2019 - 2025)

Volitionrx's Payables history spans 9 years, with the latest figure at $5.3 million for Q4 2025.

  • For Q4 2025, Payables rose 92.94% year-over-year to $5.3 million; the TTM value through Dec 2025 reached $5.3 million, up 92.94%, while the annual FY2025 figure was $5.3 million, 92.94% up from the prior year.
  • Payables reached $5.3 million in Q4 2025 per VNRX's latest filing, up from $4.6 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $5.3 million in Q4 2025 to a low of $1.1 million in Q2 2021.
  • Average Payables over 5 years is $2.9 million, with a median of $3.0 million recorded in 2023.
  • Peak YoY movement for Payables: surged 140.24% in 2022, then fell 24.8% in 2025.
  • A 5-year view of Payables shows it stood at $1.5 million in 2021, then surged by 97.28% to $3.0 million in 2022, then increased by 5.53% to $3.2 million in 2023, then dropped by 13.86% to $2.8 million in 2024, then soared by 92.94% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Payables are $5.3 million (Q4 2025), $4.6 million (Q3 2025), and $2.5 million (Q2 2025).